BIOR - BIORA THERAPEUTICS, INC.

QQQ $ 479.76 $ 5.15 (1.08 %)

DIA $ 411.97 $ 4.35 (1.07 %)

SPY $ 562.00 $ 5.91 (1.06 %)

TLT $ 98.37 $ 0.64 (0.65 %)

GLD $ 231.99 $ 2.65 (1.16 %)

Previous Close

$ 0.678

Open

Bid

$ 0.58 x 510

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.48 - $ 3.38

Volume

179,632

Average Volume

Market Cap

24.73M

Beta (5Y Monthly)

$ 1.70

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2024	06-30-2024	10-Q
2	05-15-2024	03-31-2024	10-Q
3	04-01-2024	12-31-2023	10-K
4	11-13-2023	09-30-2023	10-Q
5	08-14-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-30-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-15-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	03-28-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-18-2021	12-31-2020	10-K
16	11-09-2020	09-30-2020	10-Q
17	08-14-2020	06-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Bior...
08/13/2024 18:04:10

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biora Therapeutics (NASDAQ:BIOR) with a Buy and maintains $15 pr...

Biora Therapeutics Q2 2024 GAAP EPS $(0.04...
08/12/2024 20:38:13

Biora Therapeutics (NASDAQ:BIOR) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(...

Biora Therapeutics Inks Financing Agreemen...
08/12/2024 20:09:28

HC Wainwright & Co. Reiterates Buy on Bior...
07/22/2024 10:41:20

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biora Therapeutics (NASDAQ:BIOR) with a Buy and maintains $15 pr...

Biora Therapeutics Announces Presentation ...
07/18/2024 12:01:57

Biora Therapeutics Announces Clinical Tria...
07/01/2024 12:01:49

Drug-device combination leverages Biora's NaviCap™ platform to deliver tofacitinib directly to colonic tissue as a potentia...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
06/17/2024 20:31:09

Biora Therapeutics Says Company Did Not Re...
06/14/2024 20:35:26

-SEC Filing

Biora Therapeutics Says Notified Co That I...
06/14/2024 20:34:36

-SEC Filing-SEC Filing

Biora Therapeutics To Present On The BioJe...
06/11/2024 12:06:33

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it w...

why-netease-shares-are-trading-lower-here-are-other-stocks-moving-in-fridays-mid-day-session

Why NetEase Shares Are Trading Lower? Here...
05/24/2024 17:57:35

why-ross-stores-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket

Why Ross Stores Shares Are Trading Higher ...
05/24/2024 12:22:48

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
05/24/2024 12:07:16

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
05/23/2024 20:31:02

Biora Therapeutics To Present Clinical Dat...
05/20/2024 12:15:49

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, presented a poster titled...

HC Wainwright & Co. Reiterates Buy on Bior...
05/16/2024 15:49:23

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biora Therapeutics (NASDAQ:BIOR) with a Buy and maintains $15 pr...

Biora Therapeutics Q1 2024 GAAP EPS $(0.14...
05/15/2024 20:09:49

Biora Therapeutics (NASDAQ:BIOR) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(...

Biora Therapeutics To Present Clinical Dat...
05/06/2024 12:18:46

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it w...

Biora Therapeutics Announces Completion Of...
04/30/2024 12:07:12

Dosing of all patients in the trial has been successfully completed Final results are expected to be available in late Q2 2024S...

12 Health Care Stocks Moving In Thursday's...
04/18/2024 20:31:32